The American College of Rheumatology (ACR) today expressed its extreme disappointment with a new Centers for Medicare and Medicaid Services (CMS) decision to allow Medicare Advantage (MA) plans to implement step therapy for Part B drugs and cross-manage Part B and D drug utilization.
Model system researchers have examined the factors that influence productive activity one year after traumatic brain injury (TBI).
Researchers discovered mutations of gene IRF2BPL that are associated with a previously undiagnosed neurological disorder.
A cutting-edge laboratory technique that turns human stem cells into brain-like tissue now recapitulates human brain development more accurately than ever, according to a new study from Case Western Reserve University School of Medicine. The study, published in Nature Methods, demonstrates how to grow brain 'organoids' -- self-organizing mini spheres that now contain all the major cell types found in the human cerebral cortex -- in laboratory dishes.
Research published today in the journal Nature provides new understanding about how drugs can repair damaged brain cells that cause disability in patients with multiple sclerosis. Led by researchers at Case Western Reserve University School of Medicine, the study suggests new drug targets and potent early-stage drug candidates could lead to regenerative medicines for multiple sclerosis and other debilitating neurological diseases.
A study from the University of Kansas found individuals with disabilities were more likely to be employed in states that expanded Medicaid than their peers in non-expansion states, reducing the need to live in poverty to qualify for Medicaid coverage.
A new way to examine stress and inflammation in the heart will help Parkinson's researchers test new therapies and explore an unappreciated way the disease puts people at risk of falls and hospitalization.
Supplementing a single protein found in the spinal cord could help prevent symptoms of Lou Gehrig's disease, according to a new study out of Case Western Reserve University School of Medicine. Researchers found high levels of the protein -- called mitofusion 2 or Mfn2 -- prevented nerve degeneration, muscle atrophy, and paralysis in a mouse model of the disease. Since Mfn2 is often depleted during Lou Gehrig's, the new study suggests supplementing it could be a novel therapeutic approach for the disease.
A modest downturn for June indicated the end of 26 consecutive months of job gains for American with disabilities, according to today's National Trends in Disability Employment -- Monthly Update (nTIDE), issued by Kessler Foundation and the University of New Hampshire's Institute on Disability (UNH-IOD).
MIT engineers have developed a simple, low-cost, passive prosthetic foot that they can tailor to an individual. Given a user's body weight and size, the researchers can tune the shape and stiffness of the prosthetic foot, such that the user's walk is similar to an able-bodied gait. They estimate that the foot, if manufactured on a wide scale, could cost an order of magnitude less than existing products.